CDR2L Antikörper (C-Term)

Produktnummer ABIN927484

Produktdetails anti-CDR2L Antikörper

Target: CDR2L (Cerebellar Degeneration-Related Protein 2-Like (CDR2L))

Bindungsspezifität: C-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CDR2L Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: Purified

Immunogen: CDR2 L antibody was raised in rabbit using the C terminal of CDR2 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

CDR2L Blocking Peptide, catalog no. 33R-9763, is also available for use as a blocking control in assays to test for specificity of this CDR2L antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu CDR2L

Target: CDR2L (Cerebellar Degeneration-Related Protein 2-Like (CDR2L))

Andere Bezeichnung: CDR2L (CDR2L Produkte)

Hintergrund: The function of CDR2L remains unknown. Synonyms: Polyclonal CDR2L antibody, Anti-CDR2L antibody, cerebellar degeneration-related protein 2-like antibody, HUMPPA antibody.